Search for: "Purdue Pharmaceuticals LLC" Results 21 - 40 of 42
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Aug 2011, 11:35 pm by Marie Louise
PTO does not appear to invalidate very many gene patent method claims (Holman’s Biotech IP Blog) US: Machine-or-transformation test after Myriad: Implications to the prosecution of process claims (Patent Law Practice Center) US: Unsuccessful Qui Tam plaintiff asserting false marking claim not immune from costs award: Promote Innovation v Roche Diagnostics (Docket Report) US: FDA releases two medical device draft guidances (FDA Law Blog) US: BIO: Unleashing the promise of biotechnology (pt.4)… [read post]
16 Jan 2017, 5:44 pm by Dennis Crouch
Teva Pharmaceuticals USA, Inc., et al. [read post]
11 Jan 2022, 11:45 am by luiza
Daniel McCollum – In September, a judgment of $140 million was entered against a number of pain management clinics, drug testing laboratories, and other businesses, Oaktree Medical Centre P.C., FirstChoice Healthcare P.C., Labsource LLC, Pain Management Associates entities, ProLab LLC, and ProCare Counseling Center LLC, all of which were affiliated with South Carolina chiropractor Daniel McCollum. [read post]
11 Jan 2022, 11:45 am by luiza
Daniel McCollum – In September, a judgment of $140 million was entered against a number of pain management clinics, drug testing laboratories, and other businesses, Oaktree Medical Centre P.C., FirstChoice Healthcare P.C., Labsource LLC, Pain Management Associates entities, ProLab LLC, and ProCare Counseling Center LLC, all of which were affiliated with South Carolina chiropractor Daniel McCollum. [read post]
1 Feb 2022, 4:08 pm by Ben Vernia
The civil settlement also resolved allegations that Purdue paid kickbacks to doctors, certain specialty pharmacies and an electronic health records developer to increase prescriptions of Purdue’s opioid products. [read post]
21 Sep 2017, 6:43 am by Schachtman
For the last 30 years, Campion has been on the faculty in Purdue University. [read post]
11 Jan 2008, 9:00 am
: (Biotech Weblog),Immunomedics obtains antibody patent: (SmartBrief),Cyplasin Biomedical obtains US patent for protein based cancer treatment: (Patent Docs)Argatroban - Encysive Pharmaceuticals Inc., GlaxoSmithKline and Mitsubishi Chemical Corp. file patent infringement lawsuit to stop Barr Laboratories from producing a generic version of the anti-blood clotting drug: (IP Law360), Biaxin (Clarithromycin) - Court holds in Abbott Labs v Sandoz… [read post]
12 Jul 2022, 9:38 am by Kelly Shivery
  We suspect the Purdue Pharma opioid settlement skewed the 2021 statistics. [read post]
26 May 2015, 7:42 am
  Claims such as in Mills, which are at loggerheads with FDA criteria for drug development, are precisely those with the most potential for making pharmaceutical manufacturers into “sitting ducks” for litigation, in this instance litigation based on extraneous genetic factors.It may well be that the coming (and to some extent existing) revolution in genetically individualized medical therapy will require changes in how drugs are evaluated, labeled, etc., but this is a… [read post]